All indicators in the red
In the week from 24 to 30 March, 51,866 people in the Netherlands received a positive test result for COVID-19, an increase of 13% compared to the week before that.
Starting next week, eligible people who are not mobile enough to come to a vaccination site will be vaccinated at home. The GP will vaccinate them using the AstraZeneca vaccine. The vaccines will be delivered in phases per province.
Last year, the incidence of tuberculosis (TB) in the Netherlands fell sharply. The 17% drop is the largest in fifty years. In 2020, 623 cases were notified compared to 754 in 2019.
In the week from 17 to 23 March, 46,005 people received a positive test result for COVID-19, an increase of 16% compared to the week before that. The reproduction number continued to rise, from 1.06 on 1 March to 1.11 on 8 March.
The method developed by RIVM to assess whether waste treatment is sufficiently safe and sustainable, can contribute to the European ambitions for a safe and more circular economy.
More nitrogen and phosphorus have been ending up in the soil on farms since 2015. As a result, nitrate concentrations have been rising since 2017 in leachates and ditch water from those farms.
The Ministry of Health, Welfare and Sport (VWS) has decided to resume vaccinating with the COVID-19 vaccine made by AstraZeneca within the near future.
The downward trend in infections among nursing home residents in the Netherlands is continuing.
Five groups of patients with specific medical risks will receive an invitation for COVID-19 vaccination this week or next week. It involves four groups of patients with impaired immune systems.